Biologics May Lower Cardiovascular Risk in Patients With RA

The use of bDMARDs in patients with RA may have additional beneficial effects on arterial wall inflammation, independent of systemic inflammation.
Medscape Medical News

source https://www.medscape.com/viewarticle/biologic-drugs-may-mitigate-cardiovascular-event-risks-2024a1000epd?src=rss